Unfolding the potential-chemical chaperones in Alport syndrome.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40975521.
- Also identified by DOI 10.1016/j.kint.2025.07.006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chemical chaperones are small molecules that prevent protein aggregation by improving folding, relieving endoplasmic reticulum stress, and restoring secretion of misfolded proteins. Variants in COL4A3, COL4A4, and COL4A5 cause Alport syndrome, which is characterized by abnormal assembly, secretion, and incorporation of type IV collagen into basement membranes. Ioannou et al. discovered that the chaperone 4-phenylbutyric acid improved the basement membrane and kidney function in Alport mice, raising prospects for clinical translation of chaperone therapy in Alport syndrome.
Medical subject headings
- Nephritis, Hereditary
- Phenylbutyrates
- Molecular Chaperones